UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000013067
Receipt number R000015061
Scientific Title Phase I/II trial of subcutaneous bortezomib plus lenalidomide combined with dexamethasone combination therapy for relapsed or refractory multiple myeloma patients
Date of disclosure of the study information 2014/02/08
Last modified on 2019/03/09 10:51:49

No. Disposal Last modified on Item of update
1 Insert 2014/02/04 12:41:43
2 Update 2015/10/21 11:08:11 Recruitment status
3 Update 2019/03/09 10:51:49 Recruitment status